Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsCRISPR-Cas9 and shRNA were used to eliminate TFAP2A expression in HCT116 and a panel of colon cancer cell lines.
[Molecular Cancer Research]
6445212 {6445212:CI7Z7UET} apa 50 1 160603 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-f78495662b3a0d5b72dce654da215cc4%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22CI7Z7UET%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Beck%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EBeck%2C%20A.%20C.%2C%20Cho%2C%20E.%2C%20White%2C%20J.%20R.%2C%20Paemka%2C%20L.%2C%20Li%2C%20T.%2C%20Gu%2C%20V.%20W.%2C%20Thompson%2C%20D.%20T.%2C%20Koch%2C%20K.%20E.%2C%20Franke%2C%20C.%2C%20Gosse%2C%20M.%2C%20Wu%2C%20V.%20T.%2C%20Landers%2C%20S.%20R.%2C%20Pamatmat%2C%20A.%20J.%2C%20Kulak%2C%20M.%20V.%2C%20%26amp%3B%20Weigel%2C%20R.%20J.%20%282021%29.%20AP-2alpha%20Regulates%20S-phase%20and%20is%20a%20Marker%20for%20Sensitivity%20to%20PI3K-inhibitor%20Buparlisib%20in%20Colon%20Cancer.%20%3Ci%3EMolecular%20Cancer%20Research%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1541-7786.MCR-20-0867%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F1541-7786.MCR-20-0867%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DCI7Z7UET%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22AP-2alpha%20Regulates%20S-phase%20and%20is%20a%20Marker%20for%20Sensitivity%20to%20PI3K-inhibitor%20Buparlisib%20in%20Colon%20Cancer%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anna%20C.%22%2C%22lastName%22%3A%22Beck%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Edward%22%2C%22lastName%22%3A%22Cho%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jeffrey%20R.%22%2C%22lastName%22%3A%22White%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lily%22%2C%22lastName%22%3A%22Paemka%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Tiandao%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vivian%20W.%22%2C%22lastName%22%3A%22Gu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dakota%20T.%22%2C%22lastName%22%3A%22Thompson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kelsey%20E.%22%2C%22lastName%22%3A%22Koch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christopher%22%2C%22lastName%22%3A%22Franke%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%22%2C%22lastName%22%3A%22Gosse%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vincent%20T.%22%2C%22lastName%22%3A%22Wu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shannon%20R.%22%2C%22lastName%22%3A%22Landers%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anthony%20J.%22%2C%22lastName%22%3A%22Pamatmat%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mikhail%20V.%22%2C%22lastName%22%3A%22Kulak%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ronald%20J.%22%2C%22lastName%22%3A%22Weigel%22%7D%5D%2C%22abstractNote%22%3A%22AP-2alpha%20%28encoded%20by%20TFAP2A%29%20functions%20as%20a%20tumor%20suppressor%20and%20influences%20response%20to%20therapy%20in%20several%20cancer%20types.%20We%20aimed%20to%20characterize%20regulation%20of%20the%20transcriptome%20by%20AP-2alpha%20in%20colon%20cancer.%20CRISPR-Cas9%20and%20shRNA%20were%20used%20to%20eliminate%20TFAP2A%20expression%20in%20HCT116%20and%20a%20panel%20of%20colon%20cancer%20cell%20lines.%20AP-2alpha%20target%20genes%20were%20identified%20with%20RNA-seq%20and%20ChIP-%20seq.%20Effects%20on%20cell%20cycle%20were%20characterized%20in%20cells%20synchronized%20with%20aphidicolin%20and%20analyzed%20by%20FACS%20and%20Premo%20FUCCI.%20Effects%20on%20invasion%20and%20tumorigenesis%20were%20determined%20by%20invasion%20assay%2C%20growth%20of%20xenografts%20and%20phosphorylated%20histone%20H3%20%28PHH3%29.%20Knockout%20of%20TFAP2A%20induced%20significant%20alterations%20in%20the%20transcriptome%20including%20repression%20of%20TGM2%2C%20identified%20as%20a%20primary%20gene%20target%20of%20AP-2alpha.%20Loss%20of%20AP-2alpha%20delayed%20progression%20through%20S-phase%20into%20G2%5C%2FM%20and%20decreased%20phosphorylation%20of%20AKT%2C%20effects%20that%20were%20mediated%20through%20regulation%20of%20TGM2.%20Buparlisib%20%28BKM120%29%20repressed%20in%20vitro%20invasiveness%20of%20HCT116%20and%20a%20panel%20of%20colon%20cancer%20cell%20lines%3B%20however%2C%20loss%20of%20AP-2alpha%20induced%20resistance%20to%20Buparlisib.%20Similarly%2C%20Buparlisib%20repressed%20PHH3%20and%20growth%20of%20tumor%20xenografts%20and%20increased%20overall%20survival%20of%20tumor-bearing%20mice%2C%20whereas%2C%20loss%20of%20AP-2alpha%20induced%20resistance%20to%20the%20effect%20of%20PI3K%20inhibition.%20Loss%20of%20AP-2alpha%20in%20colon%20cancer%20leads%20to%20prolonged%20S-phase%20through%20altered%20activation%20of%20AKT%20leading%20to%20resistance%20to%20the%20PI3K%20inhibitor%2C%20Buparlisib.%20The%20findings%20demonstrate%20an%20important%20role%20for%20AP-2alpha%20in%20regulating%20progression%20through%20the%20cell%20cycle%20and%20indicates%20that%20AP-2alpha%20is%20a%20marker%20for%20response%20to%20PI3K%20inhibitors.%20Implications%3A%20AP-2alpha%20regulated%20cell%20cycle%20through%20the%20PI3K%20cascade%20and%20activation%20of%20AKT%20mediated%20through%20TGM2.%20AP-2alpha%20induced%20sensitivity%20to%20Buparlisib%5C%2FBKM120%2C%20indicating%20that%20AP-2alpha%20is%20a%20biomarker%20predictive%20of%20response%20to%20PI3K%20inhibitors.%22%2C%22date%22%3A%222021%5C%2F01%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1158%5C%2F1541-7786.MCR-20-0867%22%2C%22ISSN%22%3A%221541-7786%2C%201557-3125%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fmcr.aacrjournals.org%5C%2Fcontent%5C%2Fearly%5C%2F2021%5C%2F03%5C%2F22%5C%2F1541-7786.MCR-20-0867%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-03-26T16%3A46%3A45Z%22%7D%7D%5D%7D
Beck, A. C., Cho, E., White, J. R., Paemka, L., Li, T., Gu, V. W., Thompson, D. T., Koch, K. E., Franke, C., Gosse, M., Wu, V. T., Landers, S. R., Pamatmat, A. J., Kulak, M. V., & Weigel, R. J. (2021). AP-2alpha Regulates S-phase and is a Marker for Sensitivity to PI3K-inhibitor Buparlisib in Colon Cancer. Molecular Cancer Research. https://doi.org/10.1158/1541-7786.MCR-20-0867 Cite
